SCHEMBL2186181

SCHEMBL2186181

CC(C)Oc1cccc(CCl)c1C(F)(F)F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNK3 O14649 1/20 0.34
KCNK9 Q9NPC2 1/20 0.34
NPSR1 Q6W5P4 3/20 0.33
RXFP1 Q9HBX9 1/20 0.33
MCHR1 Q99705 1/20 0.33
IRAK4 Q9NWZ3 1/20 0.33
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
KCNH2 Q12809 1/20 0.32
RXRA P19793 1/20 0.32
RXRB P28702 1/20 0.32
RXRG P48443 1/20 0.32
MEN1 O00255 3/20 0.32
KMT2A Q03164 3/20 0.32
POLB P06746 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA7 P43166 1/20 0.32
CA9 Q16790 1/20 0.32
LMNA P02545 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28310921 0.85 GABRA1 (0.38) KCNK3KCNK9NPSR1RXFP1MCHR1
SCHEMBL16959519 0.84 KCNK3 (0.36) KCNK3KCNK9NPSR1RXFP1MCHR1
SCHEMBL2186854 0.81 MAPT (0.40) NPSR1MEN1KMT2ACA1CA2
SCHEMBL3155854 0.77 SLC6A2 (0.43) NPSR1IRAK4SLC6A2SLC6A4KCNH2
SCHEMBL16953645 0.76 KCNK3 (0.37) KCNK3KCNK9NPSR1RXFP1MCHR1
SCHEMBL16953643 0.75 KCNK3 (0.36) KCNK3KCNK9NPSR1RXFP1MCHR1
SCHEMBL16958983 0.71 ALDH1A1 (0.35) KCNK3KCNK9NPSR1RXFP1MCHR1
SCHEMBL11397648 0.71 ERN1 (0.40) KCNK3KCNK9NPSR1RXFP1MCHR1
SCHEMBL16959516 0.71 CA1 (0.38) KCNK3KCNK9RXFP1MCHR1IRAK4
SCHEMBL16958979 0.71 KCNK3 (0.34) KCNK3KCNK9NPSR1RXFP1MCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2342205-A1 SUBSTITUTED TRICYCLIC ACID DERIVATIVES AS S1P1 RECEPTOR AGONISTS USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS Arena Pharmaceuticals, Inc. (US) 2011-07-13 EP disclosed
WO-2010027431-A1 SUBSTITUTED TRICYCLIC ACID DERIVATIVES AS S1P1 RECEPTOR AGONISTS USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS ARENA PHARMACEUTICALS, INC. (US) 2010-03-11 WO disclosed